vs
Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and Incyte (INCY). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.3B, roughly 1.7× Incyte). Incyte runs the higher net margin — 23.8% vs 5.1%, a 18.7% gap on every dollar of revenue.
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
CSTM vs INCY — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.3B |
| Net Profit | $112.0M | $303.3M |
| Gross Margin | — | — |
| Operating Margin | 7.5% | 23.7% |
| Net Margin | 5.1% | 23.8% |
| Revenue YoY | — | 20.9% |
| Net Profit YoY | — | 91.7% |
| EPS (diluted) | $0.79 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.0B | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $1.9B | $1.0B |
| Q1 26 | — | $303.3M | ||
| Q4 25 | $112.0M | $299.3M | ||
| Q3 25 | $88.0M | $424.2M | ||
| Q2 25 | $36.0M | $405.0M | ||
| Q1 25 | $37.0M | $158.2M | ||
| Q4 24 | — | $201.2M | ||
| Q3 24 | — | $106.5M | ||
| Q2 24 | $76.0M | $-444.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 92.0% | ||
| Q3 25 | — | 92.8% | ||
| Q2 25 | — | 93.5% | ||
| Q1 25 | — | 93.0% | ||
| Q4 24 | — | 92.5% | ||
| Q3 24 | — | 92.4% | ||
| Q2 24 | — | 92.7% |
| Q1 26 | — | 23.7% | ||
| Q4 25 | 7.5% | 22.3% | ||
| Q3 25 | 5.8% | 32.5% | ||
| Q2 25 | 2.7% | 43.6% | ||
| Q1 25 | 3.1% | 19.5% | ||
| Q4 24 | — | 25.6% | ||
| Q3 24 | — | 12.8% | ||
| Q2 24 | 5.4% | -45.8% |
| Q1 26 | — | 23.8% | ||
| Q4 25 | 5.1% | 19.9% | ||
| Q3 25 | 4.1% | 31.1% | ||
| Q2 25 | 1.7% | 33.3% | ||
| Q1 25 | 1.9% | 15.0% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 9.4% | ||
| Q2 24 | 3.9% | -42.6% |
| Q1 26 | — | $1.47 | ||
| Q4 25 | $0.79 | $1.46 | ||
| Q3 25 | $0.62 | $2.11 | ||
| Q2 25 | $0.25 | $2.04 | ||
| Q1 25 | $0.26 | $0.80 | ||
| Q4 24 | — | $0.90 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | $0.51 | $-2.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | — |
| Total DebtLower is stronger | $1.9B | — |
| Stockholders' EquityBook value | $952.0M | $5.6B |
| Total Assets | $5.4B | $7.3B |
| Debt / EquityLower = less leverage | 2.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $120.0M | $3.1B | ||
| Q3 25 | $122.0M | $2.5B | ||
| Q2 25 | $133.0M | $2.0B | ||
| Q1 25 | $118.0M | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $987.3M |
| Q1 26 | — | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.0B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $5.6B | ||
| Q4 25 | $952.0M | $5.2B | ||
| Q3 25 | $845.0M | $4.7B | ||
| Q2 25 | $780.0M | $4.2B | ||
| Q1 25 | $745.0M | $3.7B | ||
| Q4 24 | — | $3.4B | ||
| Q3 24 | — | $3.2B | ||
| Q2 24 | $796.0M | $3.0B |
| Q1 26 | — | $7.3B | ||
| Q4 25 | $5.4B | $7.0B | ||
| Q3 25 | $5.4B | $6.3B | ||
| Q2 25 | $5.4B | $5.8B | ||
| Q1 25 | $5.2B | $5.7B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $4.7B |
| Q1 26 | — | — | ||
| Q4 25 | 2.00× | — | ||
| Q3 25 | 2.34× | — | ||
| Q2 25 | 2.53× | — | ||
| Q1 25 | 2.56× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $218.0M | — |
| Free Cash FlowOCF − Capex | $109.0M | — |
| FCF MarginFCF / Revenue | 5.0% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 1.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $218.0M | $543.3M | ||
| Q3 25 | $99.0M | $559.4M | ||
| Q2 25 | $114.0M | $44.7M | ||
| Q1 25 | $58.0M | $266.1M | ||
| Q4 24 | — | $381.2M | ||
| Q3 24 | — | $310.9M | ||
| Q2 24 | $138.0M | $-575.6M |
| Q1 26 | — | — | ||
| Q4 25 | $109.0M | — | ||
| Q3 25 | $24.0M | — | ||
| Q2 25 | $37.0M | — | ||
| Q1 25 | $-11.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $54.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.95× | 1.82× | ||
| Q3 25 | 1.13× | 1.32× | ||
| Q2 25 | 3.17× | 0.11× | ||
| Q1 25 | 1.57× | 1.68× | ||
| Q4 24 | — | 1.89× | ||
| Q3 24 | — | 2.92× | ||
| Q2 24 | 1.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
INCY
Segment breakdown not available.
